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Objective: Bay leaf, one of the plants in Indonesia that has been shown to have
activities to reduce cholesterol in the blood. HMG-CoA Reductase inhibition is
one of many mechanisms in lowering the level of cholesterol in the blood. Here,
we reported the inhibitory activity of HMG-CoA Reductase of bay leaves
ethanol extracts that we suspected to be the mechanism of action of bay leaves
in reducing cholesterol in the blood. In this research we also investigated the
correlation between the inhibitory activities, the total phenol content and
antioxidant activities of bay leaves (Syzygium polianthum) ethanol extracts.
Methods: The inhibitory activity of HMG-CoA Reductase was determined
kinetically at 340 nm using simvastatin as positive control. In vitro scavenging
assays of 2,2-diphenyl-1-picrylhydrazyl (DPPH), ferric ion reducing antioxidant
power (FRAP), and beta-carotene method were used to determine the antioxidant
activities. The total phenolic content was determined by Folin-Ciocalteu’s method.
Results: The IC50 of bay leaves ethanolic extract obtained by percolation and
soxhlet extraction method towards HMG-CoA Reductase enzyme activity were.e01485
vier Ltd. This is an open access article under the CC BY-NC-ND license
y-nc-nd/4.0/).
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simvastatin was 0.00238  0.00004 mg/mL. The antioxidant activity and total
phenolic content of bay leaves ethanolic extract obtained by Soxhlet extraction
method was higher compared to the percolation method (DPPH and beta-
carotene assay results). The 3D linear analysis showed that there was a high
correlation between the inhibition activities of HMG-CoA Reductase pattern of
both extract types and the total phenol pattern and also the antioxidant pattern of
these extracts.
Conclusion: The result showed that the bay leaves ethanolic extract have a potent
activity to reduce the cholesterol serum level by inhibition of HMG-CoA Reductase
activity. The activity was due to the phenolic compounds in the extracts as well as
the antioxidant activity of the extracts.
Keywords: Biochemistry, Molecular biology, Natural product chemistry
1. Introduction
Cardiovascular disease contributed largely to the high mortality rate worldwide year
by year. Based on the research in epidemiology, the risk factor of cardiovascular dis-
ease is a combination of two or more risk factors. The risk factors of cardiovascular
disease are classiﬁed into two groups, which are the modiﬁable risk factors (dyslipi-
demia, hypertension, smoking, diabetes mellitus, stress, obesity) and the non-
modiﬁable risk factors (heredity, age, gender). A common risk factor of cardiovas-
cular disease is high serum cholesterol level [1, 2, 3].
Cholesterol is a lipid produced in the liver with a number of important roles, such
as a membrane constituent and the parent molecule for steroid hormones [4].
Cholesterol can be synthesized by the body and also can be derived from daily
food. The increase of cholesterol level in the bloodstream can cause hypercholes-
terolemia [1]. Hypercholesterolemia is one of the risk factors for the emergence of
atherosclerosis, which is inﬂammatory disorders in artery walls characterized by
the formation of atheroma [5]. Atherosclerosis plaque could clog the heart’s blood
vessel area. This blockage then leads to cardiovascular disease [6]. The increase in
cholesterol level can be caused by excessive cholesterol synthesis, the excess of
cholesterol absorption, and high cholesterol intake from daily food. Decreasing
the cholesterol level can be done by inhibiting cholesterol synthesis through inhib-
iting the activity of HMG-CoA Reductase which converts Acetyl-CoA into meval-
onate [1, 7]. This enzyme is a pharmacological treatment target for group of drugs
called HMG-CoA Reductase inhibitor (statins) [8]. However, anti-cholesterol
drugs usually are used in combination, and this may increase the chance of unex-
pected side eﬀects in long-term use.on.2019.e01485
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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the cholesterol level [9]. Bay leaves contain secondary metabolites, such as saponin,
terpenoid, ﬂavonoid, polyphenol, alkaloid, and essential oil. Some previous in vivo
studies showed that the extract of bay leaves could lower cholesterol levels in the
animal blood [10, 11]. It is believed that ﬂavonoid (phenolic compound) as one of
the chemical content of the bay leaves plays a role in the decrease of cholesterol
levels in the blood. In addition, the research conducted by Lee et al. [12] proved
that ﬂavonoids can lower cholesterol levels by inhibiting the action of HMG-CoA
Reductase. Several experiment showed that ﬂavonoids and phenolic acids, which
are classes of polyphenolic compounds have antioxidant properties, including induc-
tion of anti-inﬂammatory actions, inhibition of oxidative enzymes, and scavenging
of free radicals [13].
Based on the researches that have been done to the animals treated with bay leaves,
further research about the potency of bay leaves as the anti-hypercholesterolemia
in vitro is needed with the enzymatic measurement. The extract of bay leaves
used was obtained by Soxhlet extraction and percolation method. The measurement
of antioxidant activities in each extract was also done to seek the correlation of anti-
oxidant activities and HMG-CoA Reductase inhibition activities. This research
covers the taxonomy of Biochemistry and Molecular Biology.2. Materials and methods
2.1. Equipment and materials
The equipment used during the study were analytical scales (Sartorius, Germany);
oven (Binder); infrared moisture balance (Kett, China); 5 mL capillary tubes; micro-
tubes (Mini spin, USA); vortex; micropipettes; blue tips; white tips; membrane ﬁl-
ters; glasswares; chamber; soxhlet; water bath; spectrophotometer (Multiscan Go,
Thermo Scientiﬁc, USA); cuvettes (Bio-Rads Lab, 2000 Alfred Nobel Drive Hercu-
les, Catalog number 9109250).
Dried bay leaves (Syzygium polyanthum) obtained from PT. HRL International
Indonesia, Pasuruan, East Java, the enzyme used was the HMG-CoA Reductase
Assay Kit (Catalog number CS 1090, Sigma, Germany), 96% ethanol, phytochem-
ical screening reagents, water for injection, sodium hydrogen phosphate (NaH2PO4)
(Merck, Indonesia), sodium dihydrogen phosphate (Na2HPO4) (Merck, Indonesia),
simvastatin tablet, antioxidant assay reagents.2.2. Preparation of extract
Standardization was done to the dried bay leaves prior to the extraction. The extrac-
tion was done with percolation and Soxhlet extraction method using ethanol 96% ason.2019.e01485
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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total 3.6 liter of solvent, while the mass used for Soxhlet extraction was 0.5 kg in
total 3.03 liter of solvent divided in several steps, which was 20 gram of dried
bay leaves in 120 ml solvent for each process. The rendemen of extract obtained
from percolation method was 25.05%, while from soxhlet extraction method was
23.62%.
The extract was then evaporated on a water bath then was stored in a sterile bottle.
The dried extract was further standardized to determine the organoleptic character-
istics, total ash content, water content, and the solubility in ethanol to ensure the
quality. Phytochemical screening was also done to the dried extract prior to antiox-
idant and enzymatic assay.2.3. HMG-CoA Reductase activity assay
366 ml 1x assay buﬀer was mixed with 24 ml HMG-CoA substrate, 8 ml NADPH, and
2 ml enzyme. The mixture was then measured at 37 C with a spectrophotometer UV
(Multiscan Go, Thermo Scientiﬁc, USA) at 340 nm wavelength and the absorbance
was read every 15 seconds for 5 minutes [14].
125 mg of bay leaves ethanol extract was dissolved in 25 ml of sterile water to
make the standard solution 5000 ppm. The solution was further made into
diﬀerent concentration: 0 ppm, 10 ppm, 25 ppm, 50 ppm, 150 ppm, 300 ppm,
600 ppm, and 1200 ppm. The solution was centrifuged and ﬁltered using a
0.45 mm ﬁlter membrane to remove the residual sediment from the extract.
364 ml 1x assay buﬀer was mixed with 24 ml HMG-CoA substrate, 8 ml NADPH,
2 ml extract from each concentration and 2 ml enzyme. The mixture was then
measured at 37 C with a spectrophotometer UV (Multiscan Go, Thermo Scien-
tiﬁc, USA) at 340 nm wavelength and the absorbance was read every 15 seconds
for 5 minutes.
Standard solution of simvastatin was taken 2 ml from each concentration 0 ppm,
0.0010 ppm, 0.0014 ppm, 0.0018 ppm, 0.0022 and 0.0026 ppm. Each 2 ml solution
was mixed with 364 ml 1x assay buﬀer, 24 ml HMG-CoA substrate, 8 ml NADPH and
2 ml enzyme. The mixture was then measured at 37 C with a spectrophotometer UV
(Multiscan Go, Thermo Scientiﬁc, USA) at 340 nm wavelength and the absorbance
was read every 15 seconds for 5 minutes.
The data from spectrophotometric was analyzed to determine the enzyme activity
(Sigma-Aldrich, 2013), using this equation:
Specific activity ¼ ðDAðsample=minÞ TVÞ
12:44V enzyme 0:6LPon.2019.e01485
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
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coeﬃcient of NADPH, V enzyme: volume of enzyme used in the assay, 0.6:
Enzyme concentration in mg-protein, LP: Lightpath in cm.2.4. Statistical analysis
All test scores were presented as mean values of inhibitionstandard deviation from
two replications. The percent of inhibition was obtained from the activity without
inhibitor minus activity with inhibitor divided by activity without inhibitor. For sta-
tistical data analysis, each group was compared using independent sample T-test
with 95% level of conﬁdence.2.5. Antioxidant assays
Antioxidant activities of the extracts were assayed by three diﬀerent methods, which
were the DPPH method, the FRAP method, and beta-carotene method. The DPPH
method states the antioxidant activity as the oxidation inhibition by referring to
Chandra and Dave [15] and Shafazila et al. [16]. The antioxidant potency was
measured using % Scavenging eﬀect. The antioxidant assay using FRAP reagent re-
fers to Benzie and Strain [17] where the antioxidant capacity stated as mmoles Tro-
lox/g dry powder. The beta-carotene assay was done according to Utami et al. [18].
The antioxidant potency of the sample was expressed as the concentration with
exhibit 50% of the antioxidant activity (EC50).2.6. Total phenolic content
Extract solution of bay leaves was prepared in diﬀerent concentration: 0 ppm, 10
ppm, 25 ppm, 50 ppm, 150 ppm, 300 ppm, 600 ppm, and 1200 ppm. Each solution
of bay leaves extract was pipetted 100 ml and was mixed with 300 ml of 2% sodium
carbonate, 1.58 ml of deionized water, and 100 ml of 10% Folin-Ciocalteu reagent.
The absorbance of the reaction mixture was observed at 750 nm (Multiscan Go,
Thermo Scientiﬁc, USA) after 30 min incubation at room temperature. Gallic acid
was used as a standard [19]. The data were expressed as ppm gallic acid equivalents.3. Results & discussion
Choosing the right extraction method is one of the supporting factors in the success
of a therapy, including lowering cholesterol level in the blood. This can be caused by
the solubility of secondary metabolites in plants depending on the type of solvent
and temperature used during extraction. From the phytochemical screening results,
both bay leaves ethanol extract (percolation method and soxhletation method)
contain alkaloid, ﬂavonoid, saponin, tannin, steroid.on.2019.e01485
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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percolation and soxhlet extraction method towards HMG-CoA Reductase enzyme
activity can be seen in Tables 1 and 2. Simvastatin, the ﬁrst generation of statins,
was used as a reference compound in this research. The inhibition potency of sim-
vastatin toward HMG-CoA Reductase enzyme is shown in Fig. 1. The IC50 value of
simvastatin measured in this study was 0.00238  0.00004 mg/mL, which is smaller
than the values found in the former researches which were about 0.00376e0.00778
mg/mL [7, 20, 21]. These values (49.50  0.700 mg/mL for extract obtained by
percolation, and 15.50  0.707 mg/mL for extract obtained by Soxhlet extraction)
were signiﬁcantly diﬀerent (p > 0.05) if compared to the IC50 of simvastatin. The
potency of ethanolic extract of bay leaves in inhibiting HMG-CoA Reductase is
smaller when compared with simvastatin, where the ability of simvastatin in inhib-
iting HMG-CoA Reductase about six thousand to twenty thousand times greater than
the ethanolic extract of bay leaves.
Several other reports have also reported the potency of plant extracts in HMG-CoA
Reductase inhibition. Opuntia ﬁcus-indica (L) Miller extract was reported by Re-
ssaissi et al. [22] to have IC50 20.3 mg/ml and said as to have moderate potency. Ade-
mosun et al. [23] reported that grapefruit peels had an IC50 on HMG-CoA Reductase
activity 0.11 mg/ml. Vernonia condensata extract showed the IC50 value of 271.7 mg/
ml [24] and Gnetum gnemon extract had an IC50 value on HMG-CoA Reductase of
400 mg/ml [25]. There are also studies that have assayed the potency of several iso-
lated chemical contents of the plants in HMG-CoA Reductase inhibition, and it was
reported that the compounds inhibit the enzyme activity with the IC50 value
8.34e149.6 mg/ml [22, 26]. Based on these several studies it can be stated that
certain plant extract is said to have HMG-CoA Reductase inhibition potency in
the range value of IC50 between 0.1 to 400 mg/ml [22, 23, 25, 27]. Thus, the ethanol
extracts of bay leaves are also a potent HMG-CoA Reductase inhibitor.Table 1. The inhibition of HMG-CoA Reductase of ethanol extract of bay leaves
obtained by percolation method.
Concentration (mg/ml) % of Inhibition Mean SD IC50 (mg/ml)
n1 n2
0 0 0 0 0 n1 ¼ 50.00
10 28.49 21.03 24.760 5.275 n2 ¼ 49.00
25 47.10 42.59 44.845 3.189
50 57.10 57.03 57.065 0.049
150 64.40 67.02 65.710 1.853
300 66.24 74.66 70.450 5.954
600 82.24 83.28 82.760 0.735
Mean  SD ¼ 49.50  0.700
on.2019.e01485
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
Table 2. The inhibition of HMG-CoA Reductase of ethanol extract of bay leaves
obtained by Soxhlet method.
Concentration (mg/ml) % of Inhibition Mean SD IC50 (mg/ml)
n1 n2
0 0 0 0 0.000 n1 ¼ 15.00
10 47.17 48.55 47.860 0.976 n2 ¼ 16.00
25 54.72 56.16 55.440 1.018
50 69.81 66.67 68.240 2.220
150 79.25 76.09 77.670 2.234
300 88.68 84.42 86.550 3.012
600 101.9 97.10 99.500 3.394
Mean  SD ¼ 15.50  0.707
7 https://doi.org/10.1016/j.heliy
2405-8440/ 2019 Published
(http://creativecommons.org/li
Article Nowe01485The potency of ethanol extract of bay leaves obtained by Soxhlet extraction is three
times higher than the potency of ethanol extract of bay leaves obtained by percola-
tion. This showed that the Soxhlet process was able to extract more active constituent
that responsible for the inhibition of HMG-CoA Reductase and that the active con-
stituents are stable under heating. It is suspected that these active constituents are
polyphenolic compounds such as gallic acid, eugenol, kaempferol and quercetin
[28]. Some studies have shown that polyphenolic compounds (luteolin, quercetin,
and isorhamnetin) contained in many plant extracts play a role in inhibiting HMG-
CoA Reductase activity [22, 27]. The phenolic compound of grapefruit peels (genis-
tein and daidzein) showed inhibition of HMG-CoA Reductase activity competitively
against HMG-CoA as substrate [23]. Flavonoids, in speciﬁc, are stated by Lee et al.
[12] to have the ability to inhibit the activity of the HMG-CoA Reductase. The
research conducted by Anggraeni [29] which states that at the same concentrationFig. 1. Graphic of HMG-CoA Reductase inhibition by simvastatin.
on.2019.e01485
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respectively 41.10% and 60.17 % also support this hypothesis. However, other
studies have not mentioned the inhibition kinetics of other ﬂavonoid groups.
The hypothesis that the inhibition of HMG-CoA Reductase in ethanol extract of
bay leaves was due to the polyphenolic content was proved by searching the cor-
relation between the inhibition activity and the total phenolic content in the extract.
Besides that, we also measured the antioxidant activity of each extract to study the
correlation of it to inhibition activity and types of extract. The total phenolic con-
tent and antioxidant activity of each concentration involved in the measurement of
HMG-CoA Reductase inhibition activity were reported in Tables 3 and 4. The total
phenol in the soxhlet extract is greater than the total phenol in the percolation
extract, which in accordance with the inhibition of HMG-CoA Reductase activity
pattern. The antioxidant activity of each extract, measured by DPPH, FRAP and
beta-carotene method, was compared to gallic acid and quercetin (Table 5). The
DPPH and beta-carotene method gave the same pattern results, which showed
that the antioxidant activity of Soxhlet extract was higher when compared to the
percolation extract. These results also in line with the inhibition of HMG-CoA
Reductase activity pattern. The FRAP method in the other way gave a diﬀerent
result, which showed that the antioxidant activity of the percolation method is
higher than that of the Soxhlet method. This could be caused by the diﬀerence
in the mechanism of the assay. FRAP method assay was based on the reduction
of ferric ion to ferrous ion. Not all of the Fe3þ reductants are antioxidant, and
some antioxidants are not able to reduce Fe3þ [30].Table 3. Total phenolic content and antioxidant activity of ethanol extract of bay
leaves obtained by percolation method.
Concentration
(mg/ml)
Total phenol
content (ppm)
Antioxidant activity
DPPH methoda FRAP methodb Beta-Carotene methodc
0 0.0A 1.9960A 0A 0.0000A
10 53.6B 3.5532B 0A 10.2513B
25 56.0B 3.8627B 0A 8.0186C
50 61.4C 5.1647C 0.9625A 13.1217D
150 99.0D 8.5790D 8.3633B 7.9707E
300 150.4E 24.9729E 21.3933C 12.5075F
600 193.7F 43.3887F 22.2472C 21.2928G
Data were obtained from three independent experiments, each performed in triplicates (n ¼ 9) and rep-
resented as mean  SD.
Values with the same letter are not signiﬁcantly diﬀerent (P < 0.05).
a IC50 was the concentration of substance that provides 50% inhibition.
b FRAP value was calculated as Ferrous Equivalents, the concentration of trolox/quercetin or extracts
which produced an absorbance value equal to that of 1 mM Fe2SO4.
c EC50 represents the eﬀective concentration at 50% of total antioxidant activity.
on.2019.e01485
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
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Table 4. Total phenolic content and antioxidant activity of ethanol extract of bay
leaves obtained by Soxhlet method.
Concentration
(mg/ml)
Total phenol
content (ppm)
Antioxidant activity
DPPH methoda FRAP methodb Beta-Carotene methodc
0 0.0A 2.2224A 0A 0A
10 35.4B 4.1808B 0A 14.9736B
25 90.8C 5.1574C 0A 15.2237C
50 92.4C 10.0685D 0A 18.4625D
150 139.0D 20.1246E 0A 20.6429E
300 187.9E 46.5714F 4.2877B 27.6990F
600 201.8F 66.9863G 19.1348C 29.0379G
Data were obtained from three independent experiments, each performed in triplicates (n ¼ 9) and rep-
resented as mean  SD.
Values with the same letter are not signiﬁcantly diﬀerent (P < 0.05).
a IC50 was the concentration of substance that provides 50% inhibition.
b FRAP value was calculated as Ferrous Equivalents, the concentration of trolox/quercetin or extracts
which produced an absorbance value equal to that of 1 mM Fe2SO4.
c EC50 represents the eﬀective concentration at 50% of total antioxidant activity.
Table 5. Antioxidant ac
Samples
Gallic Acid
Quercetin
Bay leaves ethanolic extract -
Bay leaves ethanolic extract -
Data were obtained from three
Values with the same letter ar
a IC50 was the concentration o
b FRAP value was calculated a
value equal to that of 1 mM F
cEC50 represents the eﬀective
9 https://doi.org/10.1016/j.heliy
2405-8440/ 2019 Published
(http://creativecommons.org/li
Article Nowe01485The correlation analysis between each factor in this research was done by 3D linear
analysis using SigmaPlot 12.5. The results of the analysis were shown in Tables 6, 7,
and 8. Table 6 showed the correlation between extraction method (expressed in con-
centration, x-axis) and total phenolic content (y-axis) towards antioxidant activity.
The level of correlation was shown by the R2 value. The results showed that there
is a high correlation between the extraction method and total phenolic content to-
wards antioxidant activity. The higher to total phenolic content in both extracts
will cause the increase in the antioxidant activity.tivity value of ethanol extract of bay leaves obtained by Soxhlet Method.
Antioxidant activity
DPPH method
(IC50 e ppm)
a
FRAP method
(FRAP value e ppm)b
Beta-Carotene
method (EC50 e ppm)
c
23.87  0.00A 10.60  0.01A 24.87  0.24A
48.87  0.00B 21.94  0.00B 98.44  0.39B
percolation 888.08  0.05C 295.00  0.02C 2965.62  0.65C
soxhlet 437.89  0.03D 684.00  0.03D 2230.35  1.20D
independent experiments, each performed in triplicates (n ¼ 9) and represented as mean  SD.
e not signiﬁcantly diﬀerent (P < 0.05).
f substance that provides 50% inhibition.
s Ferrous Equivalents, the concentration of trolox/quercetin or extracts which produced an absorbance
e2SO4.
concentration at 50% of total antioxidant activity.
on.2019.e01485
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
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Table 6. Correlation between extraction method and total phenolic content to-
wards antioxidant activity.
Extraction method Antioxidant method Function R2
Percolation DPPH f ¼ 0.8310 þ 0.445x þ 0.0742y 0.9890
FRAP f ¼ 0.7649 þ 0.0419xþ0.0196y 0.9663
Beta e Carotene Bleaching f ¼ 3.7012 þ 0.0068x þ 0.0652y 0.8511
Soxhlet DPPH f ¼ 5.2176 þ 0.0288x þ 0.20083y 0.9137
FRAP f ¼ 1.2690 þ 0.0465x0.0501y 0.9949
Beta e Carotene Bleaching f ¼ 5.1409 þ 0.0032x þ 0.1196y 0.9156
Table 7. Correlation between extraction method and total phenolic content to-
wards percent of HMG-CoA Reductase inhibition.
Extraction method Function R2
Percolation f ¼ 3.92410.0955x þ 0.6945y 0.8688
Soxhlet f ¼ 15.47330.0299x þ 0.4829y 0.8871
Table 8. Correlation between extraction method and antioxidant activity towards
percent of HMG-CoA Reductase inhibition.
Extraction method Antioxidant method Function R2
Percolation DPPH f ¼ 38.80520.3180x3.1319y 0.6154
FRAP f ¼ 32.6035 þ 0.0486x þ 1.1740y 0.6006
Beta e Carotene Bleaching f ¼ 15.5054 þ 0.0362x þ 2.6778y 0.7075
Soxhlet DPPH f ¼ 43.3496 þ 0.2689x2.2742y 0.5670
FRAP f ¼ 43.5523 þ 0.0533x þ 1.3197y 0.5750
Beta e Carotene Bleaching f ¼ 1.49810.0057x þ 3.4218y 0.9759
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and total phenolic content (y-axis) towards percent of HMG-CoA Reductase inhibi-
tion. There was also a strong correlation between each factor towards the inhibition
of HMG-CoA Reductase activity, but the concentration of extract gave a diﬀerent
eﬀect against the inhibition of HMG-CoA Reductase activity when compared to
the total phenolic content. It can be explained that the increase of the concentration
of extract will cause the increase also in the total phenolic content, but not all of the
phenolic compounds in the extract act as an inhibitor of HMG-CoA Reductase.
Thus, some of the phenolic compounds in the extract may act as an activator of
the HMG-CoA Reductase.
Correlation between extraction method (concentration, x-axis) and antioxidant activ-
ity (y-axis) towards percent of HMG-CoA Reductase inhibition was shown in Table
8. The results of the 3D linear analysis showed a poor correlation between the con-
centration of extract and antioxidant activity towards the inhibition of HMG-CoAon.2019.e01485
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
Fig. 2. Structure of simvastatin (A), ﬂavonoid (B), and HMG-CoA (C) [31, 32, 33].
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oxidation activity, its inhibition mechanism was not related to the antioxidant mech-
anism. We conclude that antioxidant compounds might be contributes to inhibit
HMG-CoA Reductase but does not go through in the reduction-oxidation
mechanisms.
Based on these results, it can be concluded that the inhibition of HMG-CoA Reduc-
tase activity by the percolation and soxhlet extracts are caused by the phenolic com-
pounds in the extracts, and it was suspected due to the ﬂavonoids compounds.
Further research needs to be done to conﬁrm this report. The relationship between
the ﬂavonoid structure (Fig. 2B) with its activity as an enzyme inhibitor of HMG-
CoA Reductase is due to the presence of -OH groups in C3 0, C40, and C5. It is
also caused by the C¼O group at C4. These groups play a role in forming hydrogen
bonds with amino acids from HMG-CoA Reductase through hydrophobic interac-
tion [26]. It is suspected that these groups play a role in their activity inhibiting
the HMG-CoA Reductase enzyme because they have similarities in the pharmaco-
phores group of the simvastatin. In the simvastatin structure (Fig. 2A) there is an
-OH group and a C¼O group (a pharmacophore group) that will form a bond
with the enzyme, so that the enzyme work becomes inhibited. The C¼O group in
lactone ring of simvastatin will be hydrolyzed to become an active form (acid).
The hydrolyzed simvastatin will then bind to the HMG-CoA Reductase by hydrogen
bonding with the amino acids located on the active site of the enzyme. The structure
of the hydrolyzed simvastatin in the lactone ring corresponds to the structure of the
HMG-CoA substrate (Fig. 2C) so that the enzyme is able to bind with simvastatin
and form the complex of enzymes.Declarations
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